Literature DB >> 15912374

[Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment].

C-T Germer1, H J Buhr, C Isbert.   

Abstract

Under the term "nonoperative ablation" are grouped a number of heterogeneous approaches for the treatment of liver metastases, including laser-induced thermotherapy (LITT), radio-frequency therapy (RF), and cryotherapy. In general these procedures had been intended only for palliative purposes. The establishment of clinically relevant lesion size and a lack of long-term survival data were regarded as main limitations to using them with curative intention. During the last years however, new application systems have demonstrated remarkable results in RF and LITT, and some clinical studies have shown long-term survival in selected patients comparable to that for hepatic resection. We review possibilities and limitations of nonoperative ablation procedures with curative intent, highlighting the histopathological bases of thermal ablation techniques and clinical aspects such as R0 ablation and long-term survival.

Entities:  

Mesh:

Year:  2005        PMID: 15912374     DOI: 10.1007/s00104-005-1047-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  44 in total

1.  Laser-induced thermotherapy: intra- and extralesionary recurrence after incomplete destruction of experimental liver metastasis.

Authors:  C Isbert; A Roggan; J P Ritz; G Müller; H J Buhr; K S Lehmann; C T Germer
Journal:  Surg Endosc       Date:  2001-08-16       Impact factor: 4.584

2.  Dual-probe radiofrequency ablation: an in vitro experimental study in bovine liver.

Authors:  Jeong Min Lee; Hyunchul Rhim; Joon Koo Han; Byung Jai Youn; Se Hyung Kim; Byung Ihn Choi
Journal:  Invest Radiol       Date:  2004-02       Impact factor: 6.016

3.  MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system.

Authors:  F K Wacker; K Reither; J P Ritz; A Roggan; C T Germer; K J Wolf
Journal:  J Magn Reson Imaging       Date:  2001-01       Impact factor: 4.813

4.  Heat-induced damage to HeLa-S3 cells: correlation of viability, permeability, osmosensitivity, phase-contrast light-, scanning electron- and transmission electron-microscopical findings.

Authors:  D N Wheatley; C Kerr; D W Gregory
Journal:  Int J Hyperthermia       Date:  1989 Mar-Apr       Impact factor: 3.914

5.  Low power interstitial Nd YAG laser photocoagulation in normal and neoplastic rat colon.

Authors:  K Matthewson; T Barton; M R Lewin; J P O'Sullivan; T C Northfield; S G Bown
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

6.  Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model.

Authors:  C T Germer; C Isbert; D Albrecht; A Roggan; J Pelz; J P Ritz; G Müller; H J Buhr
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  [Resection of colorectal liver metastases. What prognostic factors determine patient selection?].

Authors:  J Scheele; A Altendorf-Hofmann; T Grube; W Hohenberger; R Stangl; K Schmidt
Journal:  Chirurg       Date:  2001-05       Impact factor: 0.955

8.  Survival after repeat hepatic resection for recurrent colorectal metastases.

Authors:  A Chiappa; A P Zbar; F Biella; C Staudacher
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

Review 9.  Heating the patient: a promising approach?

Authors:  J van der Zee
Journal:  Ann Oncol       Date:  2002-08       Impact factor: 32.976

10.  Radiofrequency ablation extends the scope of surgery in colorectal liver metastases.

Authors:  A Oshowo; A R Gillams; W R Lees; I Taylor
Journal:  Eur J Surg Oncol       Date:  2003-04       Impact factor: 4.424

View more
  7 in total

Review 1.  Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update.

Authors:  Thomas J Vogl; Stephan Zangos; Katrin Eichler; Danny Yakoub; Mohamed Nabil
Journal:  Eur Radiol       Date:  2006-08-30       Impact factor: 5.315

2.  Response comparison of PLC and SLC with magnetic resonance elastography after TACE.

Authors:  Y Haas; M P Dosch; T J Vogl
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Electro-physiological parameters of hepatic radiofrequency ablation--a comparison of an in vitro versus an in vivo porcine liver model.

Authors:  R Wahba; C Bangard; R Kleinert; S Rösgen; J-H Fischer; K-J Lackner; A H Hölscher; D L Stippel
Journal:  Langenbecks Arch Surg       Date:  2009-03-14       Impact factor: 3.445

4.  Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.

Authors:  Thomas J Vogl; Nagy N N Naguib; Nour-Eldin A Nour-Eldin; Katrin Eichler; Stefan Zangos; Tatjana Gruber-Rouh
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

5.  First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).

Authors:  K Eichler; S Zangos; M G Mack; R Hammerstingl; T Gruber-Rouh; C Gallus; T J Vogl
Journal:  Int J Oncol       Date:  2012-07-25       Impact factor: 5.650

6.  Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies.

Authors:  Andreas Schicho; Philippe L Pereira; Katharina Michalik; Lukas P Beyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  Onco Targets Ther       Date:  2018-01-12       Impact factor: 4.147

7.  Evaluation of MR elastography as a response parameter for transarterial chemoembolization of colorectal liver metastases.

Authors:  Thomas J Vogl; Simon S Martin; Addison A Johnson; Yannick Haas
Journal:  Eur Radiol       Date:  2020-02-21       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.